{"id":220805,"date":"2026-06-30T00:00:00","date_gmt":"2026-06-30T00:00:00","guid":{"rendered":"http:\/\/clarivate.com\/life-sciences-healthcare\/report\/47042074-medtech-interventional-cardiology-devices-market\/"},"modified":"2026-07-21T11:07:17","modified_gmt":"2026-07-21T11:07:17","slug":"48000657-medtech-interventional-cardiology-devices-market-insights-europe","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/48000657-medtech-interventional-cardiology-devices-market-insights-europe\/","title":{"rendered":"Interventional Cardiology Devices &#8211; Market Insights &#8211; Europe"},"content":{"rendered":"<p>The European interventional cardiology device market is highly competitive and poised for moderate growth over the forecast period, driven by increasing <abbr data-abbreviation-entity=\"8917\" title=\"Percutaneous Coronary Intervention\">PCI<\/abbr> volumes for complex <abbr data-abbreviation-entity=\"8809\" title=\"Coronary Artery Disease\">CAD<\/abbr> cases and the adoption of innovative devices and technologies. Favorable clinical evidence, particularly for coronary <abbr data-abbreviation-entity=\"10133\" title=\"Intravascular Lithotripsy\">IVL<\/abbr>, will continue to propel the market forward. Additionally, the adoption of novel products and diagnostic methods is expected to expand the eligible patient population and support continued market growth in the coming years.<\/p>\n<p>This Medtech 360 Report provides comprehensive data and analysis on the state of the market for <abbr title=\"Interventional Cardiology\">IC<\/abbr> devices in Europe from 2019 through 2035.<\/p>\n<p><strong>The increasing prevalence of complex <abbr title=\"Percutaneous Coronary Intervention\">PCI<\/abbr> cases will drive demand for innovative devices and result in a higher proportion of complex <abbr data-abbreviation-entity=\"8917\" title=\"Percutaneous Coronary Intervention\">PCI<\/abbr>s.<\/strong><\/p>\n<p>Which factors are contributing to the increasing prevalence of complex <abbr title=\"Coronary Artery Disease\">CAD<\/abbr> cases?<\/p>\n<p>What factors are influencing complex <abbr title=\"Percutaneous Coronary Intervention\">PCI<\/abbr> procedure volume growth in the European <abbr title=\"Interventional Cardiology\">IC<\/abbr> device market?<\/p>\n<p>Despite the increasing prevalence of complex <abbr title=\"Percutaneous Coronary Intervention\">PCI<\/abbr>s, what factors are limiting the uptake of innovative devices in the European <abbr title=\"Interventional Cardiology\">IC<\/abbr> device market?<\/p>\n<p class=\"question-statement\"><strong>There is a growing competition in the European coronary lithotripsy device market.<\/strong><\/p>\n<p>What factors are driving growth in the treatment of calcified coronary artery disease using coronary lithotripsy in the European <abbr data-abbreviation-entity=\"8859\" title=\"Interventional Cardiology\">IC<\/abbr> market?<\/p>\n<p>What are the future prospects of the companies operating in the market?<\/p>\n<p>Which companies are expected to launch their products in the European coronary lithotripsy device market?<\/p>\n<p>Which new competitors are anticipated to enter the market?<\/p>\n<p class=\"question-statement\"><strong>Growing adoption of <abbr title=\"Coronary Computed Tomography Angiography\">CCTA<\/abbr> and FFR<sub>angio<\/sub> is reshaping diagnostic decision making in Europe, supporting more targeted patient selection for invasive evaluation.<\/strong><\/p>\n<p>How is increasing adoption of <abbr data-abbreviation-entity=\"8811\" title=\"Coronary Computed Tomography Angiography\">CCTA<\/abbr> and <abbr data-abbreviation-entity=\"8844\" title=\"Fractional Flow Reserve\">FFR<\/abbr><sub><sup>angio<\/sup><\/sub> influencing diagnostic pathways and downstream invasive procedure volumes in the European <abbr data-abbreviation-entity=\"8859\" title=\"Interventional Cardiology\">IC<\/abbr> device market?<\/p>\n<p>To what extent are <abbr data-abbreviation-entity=\"8811\" title=\"Coronary Computed Tomography Angiography\">CCTA<\/abbr> and <abbr data-abbreviation-entity=\"8844\" title=\"Fractional Flow Reserve\">FFR<\/abbr><sub>angio<\/sub> contributing to changes in <abbr data-abbreviation-entity=\"8917\" title=\"Percutaneous Coronary Intervention\">PCI<\/abbr> case selection and increasing the proportion of complex <abbr data-abbreviation-entity=\"8917\" title=\"Percutaneous Coronary Intervention\">PCI<\/abbr> procedures in Europe?<\/p>\n<p>Which European countries are leading adoption of <abbr data-abbreviation-entity=\"8811\" title=\"Coronary Computed Tomography Angiography\">CCTA<\/abbr> and <abbr data-abbreviation-entity=\"8844\" title=\"Fractional Flow Reserve\">FFR<\/abbr><sub>angio<\/sub>, and what is the impact on invasive diagnostic and <abbr data-abbreviation-entity=\"8917\" title=\"Percutaneous Coronary Intervention\">PCI<\/abbr> volumes?<\/p>\n","protected":false},"template":"","class_list":["post-220805","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-cardiovascular","medtech-therapy-area-interventional-cardiology-devices","medtech-geography-europe","medtech-date-2828"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/220805","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=220805"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}